跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CSL Malaysia Albumex 20 NexGen MY, Solution for infusion 20% - TGA Drug Approval Details
Approvals
/
TGA
/
CSL Malaysia Albumex 20 NexGen MY, Solution for infusion 20%
Approved
STANDARD
CSL Malaysia Albumex 20 NexGen MY, Solution for infusion 20%
CSL Behring (Australia) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
3fbcf668fb3f075c
Company
CSL Behring (Australia) Pty Ltd
Type
Standard
Approval Details
Approval Id
3fbcf668fb3f075c
Product Name
CSL Malaysia Albumex 20 NexGen MY, Solution for infusion 20%
Artg Id
445060
Artg Name
CSL Malaysia Albumex 20 NexGen MY, Solution for infusion 20%
Sponsor
CSL Behring (Australia) Pty Ltd
Company Detail Path
/organization/csl-behring-australia-pty-ltd
Artg Date
2024-04-02
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
3fbcf668fb3f075c
Type
Standard
Back to TGA Approvals
